Country Club Bank Amgen Inc Transaction History

Country Club Bank

$1.47 Billion
Q3 2024

A detailed history of Country Club Bank transactions in Amgen Inc stock. As of the latest transaction made, Country Club Bank holds 42,919 shares of AMGN stock, worth $12.4 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

42,919

Previous 44,406 3.35%

Holding current value

$12.4 Million

Previous $13.9 Million 0.33%

% of portfolio

0.94%

Previous 0.99%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $460,048 - $501,684	-1,487 Reduced 3.35%	42,919 $13.8 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $94,590 - $114,951	-360 Reduced 0.8%	44,406 $13.9 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $177,723 - $214,534	-661 Reduced 1.46%	44,766 $12.7 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $277,690 - $313,267	-1,086 Reduced 2.33%	45,427 $13.1 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $1.5 Million - $1.87 Million	-6,874 Reduced 12.88%	46,513 $12.5 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $264,194 - $312,405	-1,233 Reduced 2.26%	53,387 $11.9 Million
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $40,642 - $49,536	180 Added 0.33%	54,620 $13.2 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $240,023 - $304,978	-1,048 Reduced 1.89%	54,440 $14.3 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $4.48 Million - $5.06 Million	-19,977 Reduced 26.47%	55,488 $12.7 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $1.12 Million - $1.24 Million	-4,842 Reduced 6.03%	75,465 $18.5 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $17.6 Million - $19.5 Million	80,307 New	80,307 $19.5 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Club Bank , based on Form 13F filings with the SEC.

News

Stay updated on Country Club Bank with notifications on news.

Account

Country Club Bank Amgen Inc Transaction History